title: Cytomegalovirus-associated hemophagocytic syndrome in a patient with Crohn's disease receiving azathioprine.
authors.affiliation: Department of Gastroenterology, Hospital Universitario de Canarias, Tenerife, Spain; Email:dr.alejandrohc@gmail.com.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Hernández-Camba
authors.forename: Sunil
authors.initials: S
authors.lastname: Lakhwani
authors.forename: Laura
authors.initials: L
authors.lastname: Ramos
authors.forename: José Maria
authors.initials: JM
authors.lastname: Raya
authors.forename: Enrique
authors.initials: E
authors.lastname: Quintero
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects*; D001856:Bone Marrow Examination; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D051359:Lymphohistiocytosis, Hemophagocytic / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D008297:Male; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D000998:Antiviral Agents; D005765:Gastrointestinal Agents; D001379:Azathioprine